These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26801483)

  • 1. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
    Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
    J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
    Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
    J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
    Ohlow MA; Brunelli M; Schreiber M; Lauer B
    J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
    Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
    J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
    Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
    Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
    Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
    Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ig apheresis for the treatment of severe DCM patients.
    Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA
    Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option.
    Cavusoglu Y; Tahmazov S; Murat S; Akay OM
    Rev Assoc Med Bras (1992); 2023; 69(1):90-96. PubMed ID: 36629647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
    Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
    J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study.
    Staudt A; Hummel A; Ruppert J; Dörr M; Trimpert C; Birkenmeier K; Krieg T; Staudt Y; Felix SB
    Am Heart J; 2006 Oct; 152(4):712.e1-6. PubMed ID: 16996843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.
    Nagatomo Y; Baba A; Ito H; Naito K; Yoshizawa A; Kurita Y; Nakamura I; Monkawa T; Matsubara T; Wakabayashi Y; Ogawa S; Akaishi M; Yoshikawa T
    J Clin Apher; 2011; 26(1):1-8. PubMed ID: 21312253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
    Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
    J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of plasma exchange for severe dilated cardiomyopathy in children.
    Koizumi K; Hoshiai M; Toda T; Katsumata N; Kise H; Hasebe Y; Kouno Y; Kaga S; Suzuki S; Sugita K
    Heart Vessels; 2017 Jan; 32(1):61-67. PubMed ID: 27120173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
    J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.
    Hamshere S; Arnous S; Choudhury T; Choudry F; Mozid A; Yeo C; Barrett C; Saunders N; Gulati A; Knight C; Locca D; Davies C; Cowie MR; Prasad S; Parmar M; Agrawal S; Jones D; Martin J; McKenna W; Mathur A
    Eur Heart J; 2015 Nov; 36(44):3061-9. PubMed ID: 26333366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
    Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy.
    Dörffel WV; Felix SB; Wallukat G; Brehme S; Bestvater K; Hofmann T; Kleber FX; Baumann G; Reinke P
    Circulation; 1997 Apr; 95(8):1994-7. PubMed ID: 9133505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
    Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K
    J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.